20+ years leading teams in accounting, finance, treasury, investor relations, and other corporate operations functions. He serves on the Board of Landos Biopharma, Inc. (NASDAQ: LABP).

Previously: CFO of Respivant, CFO of Cytori Therapeutics, International Controller of NuVasive, 10+ years of experience in public accounting at KPMG and Ernst & Young.